会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明公开
    • NUTRACEUTICAL PLANT DERIVED MICRORNA ELEMENTS FOR TREATMENT OF CANCER
    • 微生态制剂衍生微量元素治疗癌症
    • EP3216869A1
    • 2017-09-13
    • EP16020075.4
    • 2016-03-09
    • Colizzi, Vittorio
    • CIRILLO, MarcoGALGANI, AndreaDEL GALLO DI ROCCAGIOVINE, FlaviaKENZO, MauriceMINUTOLO, AntonellaMONTESANO, CarlaMULEO, RosarioPIRRÒ, StefanoPOTESTÀ, Marina
    • C12N15/113A61K31/7088A61K31/713A61P35/00
    • The subject of the invention is a use of plant-derived miRNA molecule or its synthetic equivalent, selected from amongst plant-miR-20, plant-miR-27, plant-miR-34 or plant-miR-168a, for decreasing tumor proliferation by regulating expression of cancer-related proteins in humans. An isolated plant-functional microRNA or an extract containing said plant-functional microRNA, a preparation method therefore, and an application thereof are provided. More particularly, the invention concerns the use of an water-soluble extract of the Moninga oleifera plant seeds, as active principle, on its own or combined with at least another active principle, for preparing a nutraceutical composition used for treating or preventing cancer. The composition is easily absorbed in the cells, and has beneficial advantages selectively toxic for cancer but not normal cells. The invention therefore delivers a novel therapeutic method based on endogenous or synthetic plant-functional microRNAs capable of regulating mammalian SIRT-1 pathway associated non-plant target-genes and decreasing proliferation of human cancer cells.
    • 本发明的主题是选自植物miR-20,植物miR-27,植物miR-34或植物miR-168a的植物来源的miRNA分子或其合成等同物用于减少肿瘤增殖 通过调节癌症相关蛋白在人体内的表达。 提供了分离的植物功能性微RNA或含有所述植物功能性微RNA的提取物,其制备方法及其应用。 更具体地说,本发明涉及Moninga oleifera植物种子的水溶性提取物作为活性成分单独使用或与至少另一种活性成分组合用于制备用于治疗或预防癌症的营养组合物的用途。 该组合物易于在细胞中吸收,并具有对癌症有选择性毒性而不是正常细胞的有利优点。 因此,本发明提供了基于能够调节哺乳动物SIRT-1途径相关的非植物靶基因并减少人癌细胞增殖的内源性或合成植物功能性微RNA的新型治疗方法。